Previous close | 2.5000 |
Open | 2.5300 |
Bid | 2.5100 x 0 |
Ask | 2.5600 x 0 |
Day's range | 2.5000 - 2.5500 |
52-week range | 2.1500 - 7.5000 |
Volume | |
Avg. volume | 68,449 |
Market cap | 253.083M |
Beta (5Y monthly) | 0.95 |
PE ratio (TTM) | N/A |
EPS (TTM) | -0.0870 |
Earnings date | 29 Nov 2021 |
Forward dividend & yield | N/A (N/A) |
Ex-dividend date | N/A |
1y target est | 3.50 |
David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...
NOT FOR DISSEMINATION IN THE UNITED STATES ORFOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES. GUELPH, Ontario, Nov. 16, 2021 (GLOBE NEWSWIRE) -- Zentek Ltd. ("ZEN" or the "Company") (TSX-V:ZEN and OTC:ZENYF) a Canadian, IP development and commercialization company focused on next-gen healthcare solutions announces that it has entered into an agreement with Eight Capital as lead underwriter and sole bookrunner on behalf of a syndicate of underwriters (collectively, the “Underwriters”), pursuant to whi
Just because a business does not make any money, does not mean that the stock will go down. Indeed, ZEN Graphene...